G-quadruplexes: Targets and tools in anticancer drug design

Journal of Drug Targeting

Volumn 20, Issue 5, 2012, Pages 389-400

  Düchler, Markus ^a  

^a CENTRE OF MOLECULAR AND MACROMOLECULAR STUDIES   (Poland)

Author keywords

G rich oligonucleotide; G tetrad; Nucleolin; Telomers

Indexed keywords

ANTINEOPLASTIC AGENT; APTAMER; G RICH OLIGONUCLEOTIDE; GUANINE QUADRUPLEX; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BINDING AFFINITY; CANCER CELL; CELL DEATH; DRUG BINDING; DRUG DESIGN; DRUG TARGETING; EXON; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; INTRON; MEDLINE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CONFORMATION; PROTEIN STRUCTURE; REVIEW; RNA TRANSLATION; TELOMERE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; DRUG DESIGN; G-QUADRUPLEXES; HUMANS; NEOPLASMS; ONCOGENES; TELOMERE; TRANSCRIPTION, GENETIC;

EID: 84861051681     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2012.669384     Document Type: Review

References (117)

1. Agarwal T, Roy S, Chakraborty TK, Maiti S. (2010). Selective targeting of G-quadruplex using furan-based cyclic homooligopeptides: effect on c-MYC expression. Biochemistry, 49, 8388-8397.
2. Arora A, Dutkiewicz M, Scaria V, Hariharan M, Maiti S, Kurreck J. (2008). Inhibition of translation in living eukaryotic cells by an RNA G-quadruplex motif. RNA, 14, 1290-1296. (Pubitemid 351872187)
3. Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J. (2007). Telomeric repeat containing RNA and RNA surveillancefactors at mammalian chromosome ends. Science, 318, 798-801. (Pubitemid 351411771)
4. Balasubramanian S, Hurley LH, Neidle S. (2011). Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? Nat Rev Drug Discov, 10, 261-275.
5. Balkwill GD, Derecka K, Garner TP, Hodgman C, Flint AP, Searle MS. (2009). Repression of translation of human estrogen receptor alpha by G-quadruplex formation. Biochemistry, 48, 11487-11495.
6. Bang I. 1910. Untersuchungen über die Guanylsäure. Biochem Z, 26, 293-311.
7. Bates PJ, Laber DA, Miller DM, Thomas SD, Trent JO. (2009). Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol Pathol, 86, 151-164.
8. Brooks TA, Kendrick S, Hurley L. (2010). Making sense of G-quadruplexand i-motif functions in oncogene promoters. FEBS J, 277,3459-3469.
9. Brown RV, Danford FL, Gokhale V, Hurley LH, Brooks TA. (2011). Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex. J Biol Chem, 286, 41018-41027.
10. Bugaut A, Rodriguez R, Kumari S, Hsu ST, Balasubramanian S. (2010). Small molecule-mediated inhibition of translation by targeting anative RNA G-quadruplex. Org Biomol Chem, 8, 2771-2776.
11. Burge S, Parkinson GN, Hazel P, Todd AK, Neidle S. (2006). Quadruplex DNA: sequence, topology and structure. Nucleic Acids Res, 34,5402-5415. (Pubitemid 44742430)
12. Burger AM, Dai F, Schultes CM, Reszka AP, Moore MJ, Double JA, Neidle S. (2005). The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function. Cancer Res, 65, 1489-1496. (Pubitemid 40270178)
13. Choi EW, Nayak LV, Bates PJ. (2010). Cancer-selective antiproliferative activity is a general property of some G-rich oligodeoxynucleotides. Nucleic Acids Res, 38, 1623-1635.
14. Cogoi S, Xodo LE. (2006). G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription. Nucleic Acids Res, 34, 2536-2549. (Pubitemid 43985618)
15. Collie G, Reszka AP, Haider SM, Gabelica V, Parkinson GN, Neidle S. (2009). Selectivity in small molecule binding to human telomeric RNA and DNA quadruplexes. Chem Commun (Camb), 48, 7482-7484.
16. Collie GW, Haider SM, Neidle S, Parkinson GN. (2010). A crystallographic and modelling study of a human telomeric RNA (TERRA) quadruplex. Nucleic Acids Res, 38, 5569-5580.
17. Collie GW, Sparapani S, Parkinson GN, Neidle S. (2011). Structural basis of telomeric RNA quadruplex-acridine ligand recognition.J Am Chem Soc, 133, 2721-2728.
18. Creacy SD, Routh ED, Iwamoto F, Nagamine Y, Akman SA, Vaughn JP. (2008). G4 resolvase 1 binds both DNA and RNA tetramolecularquadruplex with high affinity and is the major source of tetramolecular quadruplex G4-DNA and G4-RNA resolving activity in HeLa cell lysates. J Biol Chem, 283, 34626-34634.
19. De Armond R, Wood S, Sun D, Hurley LH, Ebbinghaus SW. (2005). Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1alpha promoter. Biochemistry, 44, 16341-16350. (Pubitemid 41785833)
20. De Cian A, Mergny JL. (2007). Quadruplex ligands may act as molecular chaperones for tetramolecular quadruplex formation.Nucleic Acids Res, 35, 2483-2493.
21. de Lange T. (2005). Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev, 19, 2100-2110. (Pubitemid 41330312)
22. Drygin D, Siddiqui-Jain A, O'Brien S, Schwaebe M, Lin A, Bliesath J, Ho CB, Proffitt C, Trent K, Whitten JP, Lim JK, Von Hoff D, Anderes K, Rice WG. (2009). Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res, 69, 7653-7661.
23. Drygin D, Lin A, Bliesath J, Ho CB, O'Brien SE, Proffitt C, Omori M, Haddach M, Schwaebe MK, Siddiqui-Jain A, Streiner N, Quin JE, Sanij E, Bywater MJ, Hannan RD, Ryckman D, Anderes K, Rice WG. (2011). Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Res, 71, 1418-1430.
24. Du Z, Zhao Y, Li N. (2008). Genome-wide analysis reveals regulatory role of G4 DNA in gene transcription. Genome Res, 18,233-241. (Pubitemid 351240733)
25. Duechler M, Wilczynski JR. (2010). Hypoxia Inducible Factor-1 in Cancer Immune Suppression. Curr Immunol Rev, 6, 260-271.
26. Farnung BO, Giulotto E, Azzalin CM. (2010). Promoting transcription of chromosome ends. Transcription, 1, 140-143.
27. Faure-Perraud A, Métifiot M, Reigadas S, Recordon-Pinson P, Parissi V, Ventura M, Andréola ML. (2011). The guanine-quadruplexaptamer 93del inhibits HIV-1 replication ex vivo by interfering with viral entry, reverse transcription and integration. Antivir Ther (Lond), 16, 383-394.
28. Feuerhahn S, Iglesias N, Panza A, Porro A, Lingner J. (2010). TERRA biogenesis, turnover and implications for function. FEBS Lett, 584, 3812-3818.
29. Folini M, Pivetta C, Zagotto G, De Marco C, Palumbo M, Zaffaroni N, Sissi C. (2010). Remarkable interference with telomeric function by a G-quadruplex selective bisantrene regioisomer. Biochem Pharmacol, 79, 1781-1790.
30. Gatto B, Palumbo M, Sissi C. (2009). Nucleic acid aptamers based on the G-quadruplex structure: therapeutic and diagnostic potential. Curr Med Chem, 16, 1248-1265.
31. Ginisty H, Sicard H, Roger B, Bouvet P. (1999). Structure and functions of nucleolin. J Cell Sci, 112 (Pt 6), 761-772. (Pubitemid 29179310)
32. Girvan AC, Teng Y, Casson LK, Thomas SD, Jüliger S, Ball MW, Klein JB, Pierce WM Jr, Barve SS, Bates PJ. (2006). AGRO100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin. Mol Cancer Ther, 5, 1790-1799. (Pubitemid 44323247)
33. González V, Guo K, Hurley L, Sun D. (2009). Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein. J Biol Chem, 284, 23622-23635.
34. González V, Hurley LH. (2010). The C-terminus of nucleolin promotes the formation of the c-MYC G-quadruplex and inhibits c-MYCpromoter activity. Biochemistry, 49, 9706-9714.
35. Grand CL, Powell TJ, Nagle RB, Bearss DJ, Tye D, Gleason-GuzmanM, Hurley LH. (2004). Mutations in the G-quadruplex silencer element and their relationship to c-MYC overexpression, NM23 repression, and therapeutic rescue. Proc Natl Acad Sci USA, 101, 6140-6145. (Pubitemid 38520541)
36. Gray RD, Petraccone L, Trent JO, Chaires JB. (2010). Characterization of a K+-induced conformational switch in a human telomeric DNA oligonucleotide using 2-aminopurine fluorescence. Biochemistry, 49, 179-194.
37. Guan Y, Reddy KR, Zhu Q, Li Y, Lee K, Weerasinghe P, Prchal J, Semenza GL, Jing N. (2010). G-rich oligonucleotides inhibit HIF-1alpha and HIF-2alpha and block tumor growth. Mol Ther, 18, 188-197.
38. Gunaratnam M, Neidle S. (2010). An evaluation cascade for G-quadruplex telomere targeting agents in human cancer cells. Methods Mol Biol, 613, 303-313.
39. Gunaratnam M, de la Fuente M, Hampel SM, Todd AK, Reszka AP,Schätzlein A, Neidle S. (2011). Targeting pancreatic cancer with a G-quadruplex ligand. Bioorg Med Chem, 19, 7151-7157.
40. Held DM, Kissel JD, Patterson JT, Nickens DG, Burke DH. (2006). HIV-1 inactivation by nucleic acid aptamers. Front Biosci, 11, 89-112. (Pubitemid 43253477)
41. Hershman SG, Chen Q, Lee JY, Kozak ML, Yue P, Wang LS, Johnson FB. (2008). Genomic distribution and functional analyses of potential G-quadruplex-forming sequences in Saccharomyces cerevisiae. Nucleic Acids Res, 36, 144-156.
42. Hockemeyer D, Sfeir AJ, Shay JW, Wright WE, de Lange T. (2005). POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J, 24, 2667-2678. (Pubitemid 41076322)
43. Huang HS, Huang KF, Li CL, Huang YY, Chiang YH, Huang FC, Lin JJ. (2008). Synthesis, human telomerase inhibition and antiproliferative studies of a series of 2,7-bis-substituted amidoanthraquinonederivatives. Bioorg Med Chem, 16, 6976-6986.
44. Huang W, Smaldino PJ, Zhang Q, Miller LD, Cao P, Stadelman K, Wan M, Giri B, Lei M, Nagamine Y, Vaughn JP, Akman SA, Sui G. (2012). Yin Yang 1 contains G-quadruplex structures in its promoter and 5'-UTR and its expression is modulated by G4 resolvase 1. Nucleic Acids Res, 40, 1033-1049.
45. Huppert JL, Balasubramanian S. (2007). G-quadruplexes in promoters throughout the human genome. Nucleic Acids Res, 35, 406-413. (Pubitemid 46232058)
46. Incles CM, Schultes CM, Kempski H, Koehler H, Kelland LR, Neidle S. (2004). A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells. Mol Cancer Ther, 3, 1201-1206. (Pubitemid 39440164)
47. Ji X, Sun H, Zhou H, Xiang J, Tang Y, Zhao C. (2011). Research progress of RNA quadruplex. Nucleic Acid Ther, 21, 185-200.
48. Jing N, Li Y, Xu X, Sha W, Li P, Feng L, Tweardy DJ. (2003). Targeting Stat3 with G-quartet oligodeoxynucleotides in human cancer cells. DNA Cell Biol, 22, 685-696. (Pubitemid 37468167)
49. Jing N, Li Y, Xiong W, Sha W, Jing L, Tweardy DJ. (2004). G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis. Cancer Res, 64, 6603-6609. (Pubitemid 39297920)
50. Kumari S, Bugaut A, Huppert JL, Balasubramanian S. (2007). An RNA G-quadruplex in the 5' UTR of the NRAS proto-oncogene modulates translation. Nat Chem Biol, 3, 218-221. (Pubitemid 46440536)
51. Kumari S, Bugaut A, Balasubramanian S. (2008). Position and stability are determining factors for translation repression by an RNA G-quadruplex-forming sequence within the 5' UTR of the NRAS proto-oncogene. Biochemistry, 47, 12664-12669.
52. Kuryavyi V, Phan AT, Patel DJ. (2010). Solution structures of all parallelstranded monomeric and dimeric G-quadruplex scaffolds of the human c-kit2 promoter. Nucleic Acids Res, 38, 6757-6773.
53. Lattmann S, Giri B, Vaughn JP, Akman SA, Nagamine Y. (2010). Role of the amino terminal RHAU-specific motif in the recognition andresolution of guanine quadruplex-RNA by the DEAH-box RNA helicase RHAU. Nucleic Acids Res, 38, 6219-6233.
54. Lattmann S, Stadler MB, Vaughn JP, Akman SA, Nagamine Y. (2011). The DEAH-box RNA helicase RHAU binds an intramolecular RNA G-quadruplex in TERC and associates with telomerase holoenzyme. Nucleic Acids Res, 39, 9390-9404.
55. Leonetti C, Scarsella M, Riggio G, Rizzo A, Salvati E, D'Incalci M, Staszewsky L, Frapolli R, Stevens MF, Stoppacciaro A, Mottolese M, Antoniani B, Gilson E, Zupi G, Biroccio A. (2008). G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors. Clin Cancer Res, 14,7284-7291.
56. Li J, Jin X, Hu L, Wang J, Su Z. (2011). Identification of nonplanar small molecule for G-quadruplex grooves: molecular docking and molecular dynamic study. Bioorg Med Chem Lett, 21, 6969-6972.
57. Lim KW, Amrane S, Bouaziz S, Xu W, Mu Y, Patel DJ, Luu KN, Phan AT.(2009). Structure of the human telomere in K+ solution: a stable basket-type G-quadruplex with only two G-tetrad layers. J Am Chem Soc, 131, 4301-4309.
58. Lim KW, Lacroix L, Yue DJ, Lim JK, Lim JM, Phan AT. (2010). Coexistence of two distinct G-quadruplex conformations in thehTERT promoter. J Am Chem Soc, 132, 12331-12342.
59. Lipps HJ, Rhodes D. (2009). G-quadruplex structures: in vivo evidence and function. Trends Cell Biol, 19, 414-422.
60. Liu JN, Deng R, Guo JF, Zhou JM, Feng GK, Huang ZS, Gu LQ, Zeng YX, Zhu XF. (2007). Inhibition of myc promoter and telomerase activity and induction of delayed apoptosis by SYUIQ-5, a novel G-quadruplex interactive agent in leukemia cells. Leukemia, 21, 1300-1302. (Pubitemid 46831820)
61. Lixia G, Fei Y, Jiajia J, Jianhui L. (2008). Triethylene tetramine, a novel ligand of G-quadruplex, induces senescence of MCF-7 cells.Biotechnol Lett, 30, 47-53. (Pubitemid 350197809)
62. London TB, Barber LJ, Mosedale G, Kelly GP, Balasubramanian S, Hickson ID, Boulton SJ, Hiom K. (2008). FANCJ is a structurespecificDNA helicase associated with the maintenance of genomic G/C tracts. J Biol Chem, 283, 36132-36139.
63. Lopes J, Piazza A, Bermejo R, Kriegsman B, Colosio A, Teulade- Fichou MP, Foiani M, Nicolas A. (2011). G-quadruplex-inducedinstability during leading-strand replication. EMBO J, 30, 4033-4046.
64. Marcel V, Tran PL, Sagne C, Martel-Planche G, Vaslin L, Teulade- Fichou MP, Hall J, Mergny JL, Hainaut P, Van Dyck E. (2011). G-quadruplex structures in TP53 intron 3: role in alternative splicing and in production of p53 mRNA isoforms. Carcinogenesis, 32, 271-278.
65. Mason M, Schuller A, Skordalakes E. (2011). Telomerase structure function. Curr Opin Struct Biol, 21, 92-100.
66. Merle P, Evrard B, Petitjean A, Lehn JM, Teulade-Fichou MP, Chautard E, De Cian A, Guittat L, Tran PL, Mergny JL, Verrelle P, Tchirkov A. (2011). Telomere targeting with a new G4 ligand enhances radiation-induced killing of human glioblastoma cells. Mol Cancer Ther, 10, 1784-1795.
67. Micheli E, D'Ambrosio D, Franceschin M, Savino M. (2009). Watersoluble cationic perylene derivatives as possible telomerase inhibitors: the search for selective G-quadruplex targeting. Mini Rev Med Chem, 9, 1622-1632.
68. Mikami-Terao Y, Akiyama M, Yuza Y, Yanagisawa T, Yamada O, Kawano T, Agawa M, Ida H, Yamada H. (2009). Antitumor activityof TMPyP4 interacting G-quadruplex in retinoblastoma cell lines.Exp Eye Res, 89, 200-208.
69. Mongelard F, Bouvet P. (2010). AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia. Curr Opin Mol Ther, 12, 107-114.
70. Morris MJ, Basu S. (2009). An unusually stable G-quadruplex within the 5'-UTR of the MT3 matrix metalloproteinase mRNA repressestranslation in eukaryotic cells. Biochemistry, 48, 5313-5319.
71. Neidle S. (2009). The structures of quadruplex nucleic acids and their drug complexes. Curr Opin Struct Biol, 19, 239-250.
72. Neidle S. (2010). Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer. FEBS J, 277, 1118-1125.
73. Ou TM, Lu YJ, Tan JH, Huang ZS, Wong KY, Gu LQ. (2008). G-quadruplexes: targets in anticancer drug design. ChemMedChem, 3, 690-713.
74. Palumbo SL, Memmott RM, Uribe DJ, Krotova-Khan Y, Hurley LH, Ebbinghaus SW. (2008). A novel G-quadruplex-forming GGArepeat region in the c-myb promoter is a critical regulator of promoter activity. Nucleic Acids Res, 36, 1755-1769. (Pubitemid 351494223)
75. Palumbo SL, Ebbinghaus SW, Hurley LH. (2009). Formation of aunique end-to-end stacked pair of G-quadruplexes in the hTERT core promoter with implications for inhibition of telomerase by G-quadruplex-interactive ligands. J Am Chem Soc, 131,10878-10891.
76. Pasternak A, Hernandez FJ, Rasmussen LM, Vester B, Wengel J. (2011). Improved thrombin binding aptamer by incorporation of a single unlocked nucleic acid monomer. Nucleic Acids Res, 39, 1155-1164.
77. Peng D, Tan JH, Chen SB, Ou TM, Gu LQ, Huang ZS. (2010). Bisaryldiketene derivatives: A new class of selective ligandsfor c-myc G-quadruplex DNA. Bioorg Med Chem, 18, 8235-8242.
78. Pennarun G, Granotier C, Gauthier LR, Gomez D, Hoffschir F, Mandine E, Riou JF, Mergny JL, Mailliet P, Boussin FD. (2005). Apoptosis related to telomere instability and cell cycle alterations in humanglioma cells treated by new highly selective G-quadruplex ligands. Oncogene, 24, 2917-2928. (Pubitemid 40675523)
79. Phan AT. (2010). Human telomeric G-quadruplex: structures of DNAand RNA sequences. FEBS J, 277, 1107-1117.
80. Phatak P, Cookson JC, Dai F, Smith V, Gartenhaus RB, Stevens MF, Burger AM. (2007). Telomere uncapping by the G-quadruplex ligand RHPS4 inhibits clonogenic tumour cell growth in vitro and in vivo consistent with a cancer stem cell targeting mechanism. Br J Cancer, 96, 1223-1233. (Pubitemid 46625068)
81. Qin Y, Hurley LH. (2008). Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions. Biochimie, 90, 1149-1171.
82. Raiber EA, Kranaster R, Lam E, Nikan M, Balasubramanian S. (2012). A non-canonical DNA structure is a binding motif for thetranscription factor SP1 in vitro. Nucleic Acids Res, 40, 1499-1508.
83. Redon S, Reichenbach P, Lingner J. (2010). The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase. Nucleic Acids Res, 38, 5797-5806.
84. Reinhold WC, Mergny JL, Liu H, Ryan M, Pfister TD, Kinders R, Parchment R, Doroshow J, Weinstein JN, Pommier Y. (2010). Exon array analyses across the NCI-60 reveal potential regulation ofTOP1 by transcription pausing at guanosine quartets in the first intron. Cancer Res, 70, 2191-2203.
85. Reyes-Reyes EM, Teng Y, Bates PJ. (2010). A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism. Cancer Res, 70, 8617-8629.
86. Rizzo A, Salvati E, Porru M, D'Angelo C, Stevens MF, D'Incalci M, Leonetti C, Gilson E, Zupi G, Biroccio A. (2009). Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway. Nucleic Acids Res, 37, 5353-5364.
87. Rzuczek SG, Pilch DS, Liu A, Liu L, LaVoie EJ, Rice JE. (2010). Macrocyclic pyridyl polyoxazoles: selective RNA and DNA G-quadruplex ligands as antitumor agents. J Med Chem, 53, 3632-3644.
88. Salvati E, Leonetti C, Rizzo A, Scarsella M, Mottolese M, Galati R, Sperduti I, Stevens MF, D'Incalci M, Blasco M, Chiorino G,Bauwens S, Horard B, Gilson E, Stoppacciaro A, Zupi G, Biroccio A. (2007). Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. J Clin Invest, 117, 3236-3247. (Pubitemid 350096981)
89. Salvati E, Scarsella M, Porru M, Rizzo A, Iachettini S, Tentori L,Graziani G, D'Incalci M, Stevens MF, Orlandi A, Passeri D, Gilson E, Zupi G, Leonetti C, Biroccio A. (2010). PARP1 is activated at telomeres upon G4 stabilization: possible target for telomerebased therapy. Oncogene, 29, 6280-6293.
90. Sanders CM. (2010). Human Pif1 helicase is a G-quadruplex DNAbindingprotein with G-quadruplex DNA-unwinding activity. Biochem J, 430, 119-128.
91. Sarkies P, Murat P, Phillips LG, Patel KJ, Balasubramanian S, Sale JE. (2012). FANCJ coordinates two pathways that maintain epigenetic stability at G-quadruplex DNA. Nucleic Acids Res, 40, 1485-1498.
92. Satyanarayana M, Kim YA, Rzuczek SG, Pilch DS, Liu AA, Liu LF, Rice JE, LaVoie EJ. (2010). Macrocyclic hexaoxazoles: Influenceof aminoalkyl substituents on RNA and DNA G-quadruplex stabilization and cytotoxicity. Bioorg Med Chem Lett, 20, 3150-3154.
93. Schaffitzel C, Berger I, Postberg J, Hanes J, Lipps HJ, Plückthun A. (2001). In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei. Proc Natl Acad Sci USA, 98, 8572-8577. (Pubitemid 32678069)
94. Schwartz TR, Vasta CA, Bauer TL, Parekh-Olmedo H, Kmiec EB. (2008). G-rich oligonucleotides alter cell cycle progression and induce apoptosis specifically in OE19 esophageal tumor cells. Oligonucleotides, 18, 51-63.
95. Shahid R, Bugaut A, Balasubramanian S. (2010). The BCL-2 5' untranslated region contains an RNA G-quadruplex-forming motif that modulates protein expression. Biochemistry, 49, 8300-8306.
96. Shalaby T, Hiyama E, Grotzer MA. (2010a). Telomere maintenance as therapeutic target in embryonal tumours. Anticancer Agents Med Chem, 10, 196-212.
97. Shalaby T, von Bueren AO, Hürlimann ML, Fiaschetti G, Castelletti D, Masayuki T, Nagasawa K, Arcaro A, Jelesarov I, Shin-ya K, Grotzer M. (2010b). Disabling c-Myc in childhood medulloblastoma and atypical teratoid/rhabdoid tumor cells by the potent G-quadruplex interactive agent S2T1-6OTD. Mol Cancer Ther, 9, 167-179.
98. Shammas MA, Shmookler Reis RJ, Akiyama M, Koley H, Chauhan D, Hideshima T, Goyal RK, Hurley LH, Anderson KC, MunshiNC. (2003). Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma. Mol Cancer Ther, 2, 825-833.
99. Soundararajan S, Chen W, Spicer EK, Courtenay-Luck N, Fernandes DJ. (2008). The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res, 68, 2358-2365. (Pubitemid 351521810)
100. Soundararajan S, Wang L, Sridharan V, Chen W, Courtenay-Luck N, Jones D, Spicer EK, Fernandes DJ. (2009). Plasma membranenucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells. Mol Pharmacol, 76, 984-991.
101. Storck S, Shukla M, Dimitrov S, Bouvet P. (2007). Functions of thehistone chaperone nucleolin in diseases. Subcell Biochem, 41, 125-144.
102. Sumi M, Tauchi T, Sashida G, Nakajima A, Gotoh A, Shin-Ya K, Ohyashiki JH, Ohyashiki K. (2004). A G-quadruplex-interactiveagent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia. Int J Oncol, 24, 1481-1487.
103. Sun D, Liu WJ, Guo K, Rusche JJ, Ebbinghaus S, Gokhale V, Hurley LH. (2008). The proximal promoter region of the human vascular endothelial growth factor gene has a G-quadruplex structure that can be targeted by G-quadruplex-interactive agents. Mol Cancer Ther, 7, 880-889. (Pubitemid 351551041)
104. Tahara H, Shin-Ya K, Seimiya H, Yamada H, Tsuruo T, Ide T. (2006). G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells. Oncogene, 25, 1955-1966.
105. Tauchi T, Shin-Ya K, Sashida G, Sumi M, Nakajima A, Shimamoto T, Ohyashiki JH, Ohyashiki K. (2003). Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATMdependent DNA damage response pathways. Oncogene, 22,5338-5347. (Pubitemid 37056096)
106. Tauchi T, Shin-ya K, Sashida G, Sumi M, Okabe S, Ohyashiki JH, Ohyashiki K. (2006). Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia. Oncogene, 25, 5719-5725. (Pubitemid 44435249)
107. Tian M, Zhang X, Li Y, Ju Y, Xiang J, Zhao C, Tang Y. (2010). Inducement of G-quadruplex DNA forming and down-regulation of oncogene c-myc by bile acid-amino acid conjugate-BAA. Nucleosides Nucleotides Nucleic Acids, 29, 190-199.
108. Verma A, Yadav VK, Basundra R, Kumar A, Chowdhury S. (2009). Evidence of genome-wide G4 DNA-mediated gene expression inhuman cancer cells. Nucleic Acids Res, 37, 4194-4204.
109. Viglasky V. (2009). Platination of telomeric sequences and nuclease hypersensitive elements of human c-myc and PDGF-A promoters and their ability to form G-quadruplexes. FEBS J, 276, 401-409.
110. Wang P, Leung CH, Ma DL, Yan SC, Che CM. (2010). Structure-based design of platinum(II) complexes as c-myc oncogene downregulators and luminescent probes for G-quadruplex DNA. Chemistry, 16, 6900-6911.
111. Wu Y, Shin-ya K, Brosh RM Jr. (2008). FANCJ helicase defective in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to defend genomic stability. Mol Cell Biol, 28, 4116-4128. (Pubitemid 351812995)
112. Wu Y, Brosh RM Jr. (2010). G-quadruplex nucleic acids and human disease. FEBS J, 277, 3470-3488.
113. Xin H, Liu D, Wan M, Safari A, Kim H, Sun W, O'Connor MS, Songyang Z. (2007). TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature, 445, 559-562. (Pubitemid 46197638)
114. Xu Y, Sugiyama H. (2006). Formation of the G-quadruplex and i-motif structures in retinoblastoma susceptibility genes (Rb). Nucleic Acids Res, 34, 949-954. (Pubitemid 43380678)
115. Xu Y, Suzuki Y, Ito K, Komiyama M. (2010). Telomeric repeatcontaining RNA structure in living cells. Proc Natl Acad Sci USA,107, 14579-14584.
116. Zavyalova E, Golovin A, Reshetnikov R, Mudrik N, Panteleyev D, Pavlova G, Kopylov A. (2011). Novel modular DNA aptamer for human thrombin with high anticoagulant activity. Curr Med Chem, 18, 3343-3350.
117. Zhou JM, Zhu XF, Lu YJ, Deng R, Huang ZS, Mei YP, Wang Y, Huang WL, Liu ZC, Gu LQ, Zeng YX. (2006). Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines. Oncogene, 25, 503-511. (Pubitemid 43164461)